Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir

PF-07321332/ritonavir administered orally as a single dose on Day 1, Period 1

In Period 2, Days 1-3, participants will receive low-dose of carbamazepine twice daily (BID), then a titrated mid-dose of carbamazepine BID on Days 4-7, and finally maintaining carbamazepine at the high-dose on Days 8-15.

In Period 2, Day 14, participants will receive a single dose of PF-07321332/ritonavir orally.